XENE FY 2019 Earnings — Xenon Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

XENEXenon Pharmaceuticals Inc.

$5B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$7M

Gross Profit

$7M100.0% margin

Operating Income

-$43M-627.0% margin

Net Income

-$42M-609.1% margin

EPS (Diluted)

$-1.54

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$6M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$148M

Total Liabilities

$56M

Stockholders' Equity

$92M

Cash & Equivalents

$25M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$0	—
Gross Profit	$7M	-$6M	+213.8%
Operating Income	-$43M	-$38M	-12.6%
Net Income	-$42M	-$34M	-20.6%